408
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients

, &
Pages 751-760 | Accepted 11 Jan 2011, Published online: 05 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sebastiano Mercadante. (2018) Treating breakthrough pain in oncology. Expert Review of Anticancer Therapy 18:5, pages 445-449.
Read now
Sebastiano Mercadante. (2017) Fentanyl products in the management of episodic pain in the cancer patient. Expert Review of Quality of Life in Cancer Care 2:1, pages 41-45.
Read now
Donald R Taylor. (2013) Single-dose fentanyl sublingual spray for breakthrough cancer pain. Clinical Pharmacology: Advances and Applications 5, pages 131-141.
Read now
Mellar P Davis. (2011) Fentanyl for breakthrough pain: a systematic review. Expert Review of Neurotherapeutics 11:8, pages 1197-1216.
Read now

Articles from other publishers (11)

Stefan Wirz, Michael Schenk, Hannes Hofbauer, Hans-Christian Wartenberg, Marco Cascella & Kristin Kieselbach. (2020) Nicht-indikationsgemäßer Einsatz schnell freisetzender FentanylzubereitungenUse of rapid-onset fentanyl preparations beyond indication. Der Schmerz 35:2, pages 114-123.
Crossref
岚 邵. (2019) Current Research and Advances in Cancer Breakthrough Pain. Advances in Clinical Medicine 09:03, pages 257-267.
Crossref
Sebastiano Mercadante & Russell K. Portenoy. (2016) Breakthrough cancer pain: twenty-five years of study. Pain 157:12, pages 2657-2663.
Crossref
. (2016) ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products. Journal of Medical Toxicology 12:2, pages 211-212.
Crossref
Harold Minkowitz, Janet Bull, R. Charles Brownlow, Neha Parikh & Richard Rauck. (2016) Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain. Supportive Care in Cancer 24:6, pages 2669-2675.
Crossref
Jordi Guitart, Isabel Vargas, Vicente De Sanctis, Julia Ferreras, Jose Fuentes, Rafael Salazar, Juan M. Vázquez, Jordi Folch, Jordi Moya, Hermann Ribera, Francisco Rodelas, Albert Tomás, María Arilla, Joan Coma, Teresa Aberasturi, Dolores Sintes & Ester Lombán. (2013) Efficacy and Safety of Sublingual Fentanyl Orally Disintegrating Tablets in Patients with Breakthrough Pain: Multicentre Prospective Study. Clinical Drug Investigation 33:9, pages 675-683.
Crossref
Ingrid Schubert, Peter Ihle & Rainer Sabatowski. (2013) Increase in Opiate Prescription in Germany Between 2000 and 2010. Deutsches Ärzteblatt international.
Crossref
Tim Geary, Anna Negus, Brian J. Anderson & Boris Zernikow. (2011) Perioperative management of the child on long‐term opioids. Pediatric Anesthesia 22:3, pages 189-202.
Crossref
. (2012) Current World Literature. Current Opinion in Supportive & Palliative Care 6:1, pages 109-125.
Crossref
Sebastiano Mercadante. (2012) Pharmacotherapy for Breakthrough Cancer Pain. Drugs 72:2, pages 181-190.
Crossref
Sebastiano Mercadante. (2011) Fentanyl buccal tablets for the treatment of breakthrough pain. Pain Management 1:6, pages 533-538.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.